1. Home
  2. SEI vs COGT Comparison

SEI vs COGT Comparison

Compare SEI & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEI
  • COGT
  • Stock Information
  • Founded
  • SEI 2014
  • COGT 2014
  • Country
  • SEI United States
  • COGT United States
  • Employees
  • SEI N/A
  • COGT N/A
  • Industry
  • SEI
  • COGT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEI
  • COGT Health Care
  • Exchange
  • SEI NYSE
  • COGT Nasdaq
  • Market Cap
  • SEI 681.1M
  • COGT 545.3M
  • IPO Year
  • SEI 2017
  • COGT 2018
  • Fundamental
  • Price
  • SEI $21.78
  • COGT $4.81
  • Analyst Decision
  • SEI Strong Buy
  • COGT Buy
  • Analyst Count
  • SEI 5
  • COGT 7
  • Target Price
  • SEI $48.25
  • COGT $14.00
  • AVG Volume (30 Days)
  • SEI 1.5M
  • COGT 1.3M
  • Earning Date
  • SEI 04-28-2025
  • COGT 05-06-2025
  • Dividend Yield
  • SEI 2.22%
  • COGT N/A
  • EPS Growth
  • SEI N/A
  • COGT N/A
  • EPS
  • SEI 0.50
  • COGT N/A
  • Revenue
  • SEI $371,533,000.00
  • COGT N/A
  • Revenue This Year
  • SEI $60.08
  • COGT N/A
  • Revenue Next Year
  • SEI $33.81
  • COGT N/A
  • P/E Ratio
  • SEI $42.93
  • COGT N/A
  • Revenue Growth
  • SEI 33.59
  • COGT N/A
  • 52 Week Low
  • SEI $8.09
  • COGT $3.72
  • 52 Week High
  • SEI $39.03
  • COGT $12.61
  • Technical
  • Relative Strength Index (RSI)
  • SEI N/A
  • COGT 44.64
  • Support Level
  • SEI N/A
  • COGT $4.55
  • Resistance Level
  • SEI N/A
  • COGT $5.89
  • Average True Range (ATR)
  • SEI 0.00
  • COGT 0.38
  • MACD
  • SEI 0.00
  • COGT 0.09
  • Stochastic Oscillator
  • SEI 0.00
  • COGT 34.55

About SEI SOLARIS ENERGY INFRASTRUCTURE INC

Solaris Energy Infrastructure Inc provides services in the oil and gas industry. Its solutions are Solaris software suite, Fluid management system, Automated control systems, Field services, Last mile management, Wet sand solutions, Power Solutions, and Integrated wellsite solution. Its segment include Solaris Power Solutions and Solaris Logistics Solutions. It derives maximum revenue from Solaris Logistics Solutions segment.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: